The table below compares all 193 Generic Drugs companies on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TEVA | Teva Pharmaceutical Industries Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.84 Bn | 61.56 | 2.47 | 39.19 Bn |
| 2 | VTRS | Viatris Inc | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.13 Bn | -46.58 | 1.30 | 18.24 Bn |
| 3 | RDY | Dr Reddys Laboratories Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.91 Bn | 785.46 | 2.70 | 9.74 Bn |
| 4 | AMRX | Amneal Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.51 Bn | 25.57 | 1.77 | 5.38 Bn |
| 5 | BHC | Bausch Health Companies Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.30 Bn | -2.11 | 0.21 | 0.46 Bn |
| 6 | ALVO | Alvotech | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -5.39 | 4.38 | 1.36 Bn |
| 7 | ANIP | Ani Pharmaceuticals Inc | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 13.80 | 1.52 | 1.13 Bn |
| 8 | AMPH | Amphastar Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.00 Bn | 12.03 | 1.38 | 0.71 Bn |
| 9 | FENC | Fennec Pharmaceuticals Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.40 Bn | -90.65 | 7.48 | 0.36 Bn |
| 10 | RDHL | RedHill Biopharma Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -434.89 | 37.17 | 0.18 Bn |
| 11 | NTRB | NutriBand Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -10.11 | 43.51 | 0.07 Bn |
| 12 | BGM | BGM Group Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | — | — | 0.02 Bn |
| 13 | ETST | Earth Science Tech, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 6.76 | 0.72 | 0.02 Bn |
| 14 | NXPL | NextPlat Corp | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.54 | 0.52 | 0.01 Bn |
| 15 | COSM | Cosmos Health Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.76 | 0.21 | 0.01 Bn |
| 16 | SCNX | Scienture Holdings, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.89 | 34.94 | 0.01 Bn |
| 17 | AEON | AEON Biopharma, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.24 | — | 0.01 Bn |
| 18 | PMHS | Polomar Health Services, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.59 | 1.78 | 0.01 Bn |
| 19 | SXTP | 60 Degrees Pharmaceuticals, Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.38 | 2.25 | 0.00 Bn |
| 20 | SBFM | Sunshine Biopharma Inc. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.27 | 0.04 | -0.01 Bn |
| 21 | QNRX | Quoin Pharmaceuticals, Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 22 | PRFX | PRF Technologies Ltd. | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.18 | 53.74 | -0.01 Bn |
| 23 | GRMLW | Greenland Mines Ltd | primary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | — | -0.01 Bn |
| 24 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 643.26 Bn | 30.58 | 6.57 | 622.50 Bn |
| 25 | ABT | Abbott Laboratories | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 183.04 Bn | 33.74 | 3.93 | 177.44 Bn |
| 26 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 180.92 Bn | -62.49 | 5.94 | 177.74 Bn |
| 27 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 158.57 Bn | 36.30 | 2.49 | 146.88 Bn |
| 28 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.16 Bn | 30.00 | 10.50 | 124.30 Bn |
| 29 | FCX | Freeport-Mcmoran Inc | secondary | M-10 | Metals and Mining | MG-02 | 109.93 Bn | 32.84 | 4.25 | 105.85 Bn |
| 30 | EOG | Eog Resources Inc | secondary | E-02 | Oil and Gas Upstream | EG-01 | 77.26 Bn | 11.24 | 2.86 | 72.36 Bn |
| 31 | BIIB | Biogen Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 31.15 Bn | 37.32 | 3.11 | 29.86 Bn |
| 32 | MLM | Martin Marietta Materials Inc | secondary | M-18 | Construction Materials | MG-03 | 30.29 Bn | 12.44 | 4.53 | 30.17 Bn |
| 33 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 30.05 Bn | -20.25 | 2,751.33 | 30.05 Bn |
| 34 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.99 Bn | -31.97 | 24.60 | 26.83 Bn |
| 35 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.67 Bn | 16.53 | 6.87 | 19.01 Bn |
| 36 | SQM | Chemical & Mining Co Of Chile Inc | secondary | M-11 | Metals and Mining | MG-02 | 21.57 Bn | 6.36 | 3.21 | 17.22 Bn |
| 37 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.65 Bn | 22.19 | 4.64 | 15.26 Bn |
| 38 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 12.66 Bn | 550.61 | 1.14 | 10.51 Bn |
| 39 | BMRN | Biomarin Pharmaceutical Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.45 Bn | 170.57 | 3.65 | 11.57 Bn |
| 40 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.16 Bn | 224.28 | 14.63 | 11.85 Bn |
| 41 | KRYS | Krystal Biotech, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 10.27 Bn | 42.55 | 23.32 | 9.43 Bn |
| 42 | IBRX | ImmunityBio, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 8.47 Bn | -8.54 | 51.11 | 8.12 Bn |
| 43 | TGTX | Tg Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.77 Bn | 17.59 | 9.72 | 7.09 Bn |
| 44 | ACA | Arcosa, Inc. | secondary | I-09 | Machinery | IG-02 | 7.15 Bn | 14.54 | 2.60 | 6.71 Bn |
| 45 | HIMS | Hims & Hers Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 6.41 Bn | -45.14 | 2.49 | 5.57 Bn |
| 46 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.33 Bn | -38.86 | 1.19 | 5.96 Bn |
| 47 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.14 Bn | 44.31 | 13.62 | 5.86 Bn |
| 48 | MTRN | MATERION Corp | secondary | M-16 | Metals and Mining | MG-02 | 5.30 Bn | 58.78 | 2.52 | 5.28 Bn |
| 49 | CRSP | CRISPR Therapeutics AG | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 5.17 Bn | -10.68 | 385.71 | 5.17 Bn |
| 50 | IOVA | Iovance Biotherapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.79 Bn | -18.13 | 11.66 | 3.49 Bn |
| 51 | LEGN | Legend Biotech Corp | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.68 Bn | -174.54 | 2.89 | 2.71 Bn |
| 52 | UUUU | Energy Fuels Inc | secondary | E-13 | Coal and Uranium | EG-05 | 3.63 Bn | -44.04 | 34.36 | 2.70 Bn |
| 53 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | 17.20 | 0.59 | 2.46 Bn |
| 54 | USLM | United States Lime & Minerals Inc | secondary | M-16 | Metals and Mining | MG-02 | 3.32 Bn | 24.74 | 8.82 | 2.92 Bn |
| 55 | PPTA | Perpetua Resources Corp. | secondary | M-13 | Metals and Mining | MG-02 | 3.10 Bn | -12.96 | — | 3.10 Bn |
| 56 | QURE | uniQure N.V. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.05 Bn | -15.49 | 163.16 | 3.05 Bn |
| 57 | BEAM | Beam Therapeutics Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.65 Bn | -30.97 | 16.96 | 2.65 Bn |
| 58 | PGEN | Precigen, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | -7.26 | 28.50 | 2.44 Bn |
| 59 | NGVT | Ingevity Corp | secondary | M-02 | Chemicals | MG-01 | 2.36 Bn | 43.72 | 2.03 | 2.18 Bn |
| 60 | SRPT | Sarepta Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.33 Bn | -16.97 | 1.18 | 1.53 Bn |
| 61 | MTX | Minerals Technologies Inc | secondary | M-16 | Metals and Mining | MG-02 | 2.16 Bn | -7.89 | 1.00 | 1.81 Bn |
| 62 | VCEL | Vericel Corp | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.99 Bn | 79.32 | 6.50 | 1.83 Bn |
| 63 | TSHA | Taysha Gene Therapies, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.97 Bn | -13.18 | 359.62 | 1.97 Bn |
| 64 | TMC | TMC the metals Co Inc. | secondary | M-10 | Metals and Mining | MG-02 | 1.86 Bn | -5.17 | — | 1.76 Bn |
| 65 | AESI | Atlas Energy Solutions Inc. | secondary | M-16 | Metals and Mining | MG-02 | 1.82 Bn | -15.37 | 1.70 | 1.65 Bn |
| 66 | GLPGF | Lakefront Biotherapeutics NV | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.73 Bn | 0.00 | 1.50 | 1.73 Bn |
| 67 | NTLA | Intellia Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.64 Bn | -4.11 | 27.59 | 1.64 Bn |
| 68 | NRP | Natural Resource Partners Lp | secondary | E-03 | Oil and Gas Upstream | EG-01 | 1.49 Bn | 14.04 | 7.49 | 1.46 Bn |
| 69 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.47 Bn | -3.17 | 2.04 | 1.17 Bn |
| 70 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -42.04 | 5.10 | 1.32 Bn |
| 71 | SLDB | Solid Biosciences Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | -6.75 | — | 1.38 Bn |
| 72 | MGTX | MeiraGTx Holdings plc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.21 Bn | 7.34 | 3.02 | 1.07 Bn |
| 73 | IMTX | Immatics N.V. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.12 Bn | -4.64 | 22.98 | 0.66 Bn |
| 74 | CMP | Compass Minerals International Inc | secondary | M-16 | Metals and Mining | MG-02 | 1.09 Bn | 59.10 | 0.84 | 1.03 Bn |
| 75 | CPAC | Cementos Pacasmayo Saa | secondary | M-17 | Construction Materials | MG-03 | 1.07 Bn | 3.08 | 0.48 | 0.87 Bn |
| 76 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | 69.58 | 1.37 | 0.77 Bn |
| 77 | ACDC | ProFrac Holding Corp. | secondary | E-10 | Oilfield Services and Equipment | EG-04 | 1.00 Bn | -2.44 | 0.56 | 0.98 Bn |
| 78 | FDMT | 4D Molecular Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.99 Bn | -5.55 | 10.80 | 0.63 Bn |
| 79 | TTI | Tetra Technologies Inc | secondary | E-10 | Oilfield Services and Equipment | EG-04 | 0.98 Bn | 157.83 | 1.52 | 0.82 Bn |
| 80 | SANA | Sana Biotechnology, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -4.42 | — | 0.95 Bn |
| 81 | CADL | Candel Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.91 Bn | -13.81 | — | 0.91 Bn |
| 82 | NGNE | Neurogene Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.85 Bn | -7.64 | — | 0.85 Bn |
| 83 | GSM | Ferroglobe PLC | secondary | M-10 | Metals and Mining | MG-02 | 0.85 Bn | -6.53 | 0.62 | 0.76 Bn |
| 84 | ODC | Oil-Dri Corp of America | secondary | M-16 | Metals and Mining | MG-02 | 0.84 Bn | 15.11 | 1.72 | 0.78 Bn |
| 85 | IMMX | Immix Biopharma, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.78 Bn | -24.76 | — | 0.78 Bn |
| 86 | UAMY | United States Antimony Corp | secondary | M-10 | Metals and Mining | MG-02 | 0.78 Bn | -162.29 | 19.32 | 0.73 Bn |
| 87 | TROX | Tronox Holdings plc | secondary | M-01 | Chemicals | MG-01 | 0.74 Bn | -1.34 | 0.24 | 0.55 Bn |
| 88 | NUAI | New ERA Energy & Digital, Inc. | secondary | E-02 | Oil and Gas Upstream | EG-01 | 0.63 Bn | -12.11 | 530.63 | 0.56 Bn |
| 89 | LOGC | ContextLogic Holdings Inc. | secondary | M-16 | Metals and Mining | MG-02 | 0.61 Bn | 73.95 | 10.62 | 0.61 Bn |
| 90 | PRME | Prime Medicine, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.61 Bn | -3.26 | 150.33 | 0.61 Bn |
| 91 | BNTC | Benitec Biopharma Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -12.40 | — | 0.57 Bn |
| 92 | ALLO | Allogene Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -3.44 | 122.99 | 0.57 Bn |
| 93 | IPI | Intrepid Potash, Inc. | secondary | M-04 | Chemicals | MG-01 | 0.54 Bn | 20.69 | 1.85 | 0.36 Bn |
| 94 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -5.57 | 54.88 | 0.45 Bn |
| 95 | AUTL | Autolus Therapeutics plc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -2.10 | 4.81 | 0.34 Bn |
| 96 | CAPR | Capricor Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -3.97 | — | 0.50 Bn |
| 97 | NEUP | Neuphoria Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -19.72 | — | 0.45 Bn |
| 98 | KYTX | Kyverna Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -3.04 | — | 0.46 Bn |
| 99 | RGNX | REGENXBIO Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -2.60 | 2.44 | 0.36 Bn |
| 100 | CABA | Cabaletta Bio, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -2.39 | — | 0.44 Bn |
| 101 | ARTV | Artiva Biotherapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -4.68 | — | 0.42 Bn |
| 102 | IPSC | Century Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -3.80 | — | 0.16 Bn |
| 103 | RCKT | Rocket Pharmaceuticals, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -23.71 | — | 0.41 Bn |
| 104 | LXEO | Lexeo Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.38 Bn | -4.41 | — | 0.38 Bn |
| 105 | OCGN | Ocugen, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.36 Bn | -4.39 | 78.38 | 0.26 Bn |
| 106 | PROK | Prokidney Corp. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.35 Bn | -2.59 | 423.07 | 0.35 Bn |
| 107 | ABEO | Abeona Therapeutics Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | -3.06 | 12.95 | 0.18 Bn |
| 108 | CLLS | Cellectis S.A. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -7.50 | 5.28 | 0.14 Bn |
| 109 | LYEL | Lyell Immunopharma, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -1.22 | 11,093.57 | 0.30 Bn |
| 110 | FATE | Fate Therapeutics Inc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -2.33 | 45.07 | 0.29 Bn |
| 111 | AGEN | Agenus Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | 3.08 | 2.13 | 0.28 Bn |
| 112 | NWBO | Northwest Biotherapeutics Inc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -7.08 | 126.60 | 0.27 Bn |
| 113 | LCTX | Lineage Cell Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -11.32 | 19.83 | 0.20 Bn |
| 114 | RNAC | Cartesian Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -2.38 | 175.17 | 0.26 Bn |
| 115 | ALEC | Alector, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.25 Bn | -2.87 | 18.17 | 0.08 Bn |
| 116 | EDIT | Editas Medicine, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.25 Bn | — | — | 0.11 Bn |
| 117 | MEOBF | Mesoblast Ltd | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.25 Bn | -4.28 | 2.05 | 0.14 Bn |
| 118 | TARA | Protara Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | -3.34 | — | 0.23 Bn |
| 119 | CELG-RI | Bristol Myers Squibb Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.03 | 0.00 | -10.83 Bn |
| 120 | NKTX | Nkarta, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.50 | — | 0.21 Bn |
| 121 | SND | Smart Sand, Inc. | secondary | M-16 | Metals and Mining | MG-02 | 0.21 Bn | 20.33 | 0.55 | 0.20 Bn |
| 122 | NMG | Nouveau Monde Graphite Inc. | secondary | M-16 | Metals and Mining | MG-02 | 0.21 Bn | 4.39 | — | -0.12 Bn |
| 123 | DERM | Journey Medical Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -55.91 | 3.00 | 0.18 Bn |
| 124 | NVA-WT | Nova Minerals Corp | secondary | M-13 | Metals and Mining | MG-02 | 0.20 Bn | — | — | 0.16 Bn |
| 125 | VYGR | Voyager Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -2.37 | 5.65 | 0.08 Bn |
| 126 | SLGL | Sol-Gel Technologies Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.55 | 108.38 | 0.15 Bn |
| 127 | DTIL | Precision Biosciences Inc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -5.46 | 4.12 | 0.10 Bn |
| 128 | EAF | Graftech International Ltd | secondary | M-16 | Metals and Mining | MG-02 | 0.16 Bn | -0.91 | 0.31 | 0.02 Bn |
| 129 | ZSQR | Z Squared Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -7.70 | 53.11 | 0.13 Bn |
| 130 | ATRA | Atara Biotherapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -6.29 | 23.87 | 0.13 Bn |
| 131 | CRBU | Caribou Biosciences, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.33 | 14.54 | 0.03 Bn |
| 132 | TNYA | Tenaya Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -1.40 | 107.84 | 0.14 Bn |
| 133 | HUMA | Humacyte, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -1.15 | 64.72 | 0.14 Bn |
| 134 | ENGN | enGene Therapeutics Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -0.99 | — | 0.13 Bn |
| 135 | HURA | TuHURA Biosciences, Inc./NV | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -4.18 | — | 0.13 Bn |
| 136 | NIOBW | Niocorp Developments Ltd | secondary | M-12 | Metals and Mining | MG-02 | 0.13 Bn | -2.12 | — | -0.18 Bn |
| 137 | NRXP | NRX Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -5.99 | 36.76 | 0.10 Bn |
| 138 | GUTS | Fractyl Health, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.10 Bn | -0.81 | — | 0.10 Bn |
| 139 | ACET | Adicet Bio, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -1.03 | — | -0.02 Bn |
| 140 | PLYX | Polaryx Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -10.06 | — | 0.09 Bn |
| 141 | ANIX | Anixa Biosciences Inc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -9.22 | — | 0.10 Bn |
| 142 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | 10.01 | 1.21 | -0.11 Bn |
| 143 | WWR | Westwater Resources, Inc. | secondary | M-16 | Metals and Mining | MG-02 | 0.07 Bn | — | — | 0.00 Bn |
| 144 | GSTX | Graphene & Solar Technologies Ltd | secondary | M-16 | Metals and Mining | MG-02 | 0.07 Bn | -31.11 | — | 0.07 Bn |
| 145 | INMB | Inmune Bio, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -3.28 | — | 0.05 Bn |
| 146 | ZTEK | Zentek Ltd. | secondary | M-02 | Chemicals | MG-01 | 0.06 Bn | -11.95 | 256.85 | 0.05 Bn |
| 147 | INKT | MiNK Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -5.15 | — | 0.06 Bn |
| 148 | APTN | Adaptin Bio, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -10.22 | — | 0.06 Bn |
| 149 | FEAM | 5E Advanced Materials, Inc. | secondary | M-16 | Metals and Mining | MG-02 | 0.05 Bn | -1.44 | — | 0.05 Bn |
| 150 | OMEX | Odyssey Marine Exploration Inc | secondary | I-15 | Construction Services | IG-04 | 0.05 Bn | -1.49 | 251.09 | 0.05 Bn |
| 151 | SGMOQ | Sangamo Therapeutics, Inc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.36 | 1.11 | 0.02 Bn |
| 152 | MGX | Metagenomi Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.47 | 2.02 | 0.04 Bn |
| 153 | TCRX | TScan Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.36 | 6.03 | 0.04 Bn |
| 154 | SER | Serina Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.45 | 315.10 | 0.02 Bn |
| 155 | ATNM | Actinium Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | 3.44 | 1.11 | 0.04 Bn |
| 156 | CELU | Celularity Inc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.42 | 1.44 | 0.03 Bn |
| 157 | ESLA | Estrella Immunopharma, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.88 | — | 0.03 Bn |
| 158 | TVGN | Tevogen Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.26 | — | 0.03 Bn |
| 159 | MRKR | Marker Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.30 | — | 0.01 Bn |
| 160 | AYTU | Aytu Biopharma, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.73 | 0.40 | 0.00 Bn |
| 161 | INAB | In8Bio, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.18 | — | 0.02 Bn |
| 162 | LGVN | Longeveron Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.88 | 17.51 | 0.01 Bn |
| 163 | GNTA | Genenta Science S.p.A. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -3.87 | — | 0.02 Bn |
| 164 | PASG | Passage BIO, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.42 | — | 0.02 Bn |
| 165 | CTXR | Citius Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.33 | 2.17 | 0.02 Bn |
| 166 | HIND | Vyome Holdings, Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.21 | 111.46 | 0.01 Bn |
| 167 | ADIA | Adia Nutrition, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -75.51 | 69.62 | 0.01 Bn |
| 168 | PLUR | Pluri Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.00 | 8.92 | 0.00 Bn |
| 169 | FBLG | FibroBiologics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.66 | — | 0.01 Bn |
| 170 | GDTC | CytoMed Therapeutics Ltd | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -3.25 | 40.49 | 0.01 Bn |
| 171 | ATCX | ATLAS CRITICAL MINERALS Corp | secondary | M-07 | Metals and Mining | MG-02 | 0.01 Bn | -2.16 | 104.49 | 0.00 Bn |
| 172 | SNTI | Senti Biosciences Holdings, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.14 | 543.57 | 0.01 Bn |
| 173 | ZEOX | Zeo ScientifiX, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -2.03 | 1.22 | 0.01 Bn |
| 174 | LNAI | Lunai Bioworks Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.06 | 96.04 | 0.01 Bn |
| 175 | SCGY | SCIENTIFIC ENERGY, INC | secondary | T-53 | Internet Platforms | TG-08 | 0.01 Bn | -0.21 | 0.09 | 0.00 Bn |
| 176 | MGRX | Mangoceuticals, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 0.01 Bn | -0.44 | 22.73 | 0.01 Bn |
| 177 | GSCCF | ioneer Ltd | secondary | M-11 | Metals and Mining | MG-02 | 0.01 Bn | -0.31 | — | -0.10 Bn |
| 178 | PMCB | PharmaCyte Biotech, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.17 | — | 0.00 Bn |
| 179 | TPST | Tempest Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.25 | — | 0.00 Bn |
| 180 | MBIO | Mustang Bio, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.17 | — | 0.00 Bn |
| 181 | ISCO | International Stem Cell CORP | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -8.80 | 0.29 | 0.00 Bn |
| 182 | CASIF | CASI Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.12 | 0.00 Bn |
| 183 | BCAB | BioAtla, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.07 | 0.27 | 0.00 Bn |
| 184 | GOVX | GeoVax Labs, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.11 | 2.56 | 0.00 Bn |
| 185 | CLDI | Calidi Biotherapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.08 | — | 0.00 Bn |
| 186 | RNAZ | Transcode Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.04 | — | 0.00 Bn |
| 187 | GNPX | Genprex, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -0.01 Bn |
| 188 | CELZ | Creative Medical Technology Holdings, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.20 | 484.98 | 0.00 Bn |
| 189 | BRTX | BioRestorative Therapies, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.08 | 3.36 | 0.00 Bn |
| 190 | RMTG | Regenerative Medical Technology Group Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.12 | 0.12 | 0.00 Bn |
| 191 | FCHS | First Choice Healthcare Solutions, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.05 | — | 0.00 Bn |
| 192 | TII | Titan Mining Corp | secondary | M-10 | Metals and Mining | MG-02 | 0.00 Bn | -0.05 | 0.00 | -0.01 Bn |
| 193 | ERNAW | Ernexa Therapeutics Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | 0.00 Bn |